These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9712731)

  • 21. Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor.
    Conway S; Drew JE; Mowat ES; Barrett P; Delagrange P; Morgan PJ
    J Biol Chem; 2000 Jul; 275(27):20602-9. PubMed ID: 10770942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors.
    Wan Q; Man HY; Liu F; Braunton J; Niznik HB; Pang SF; Brown GM; Wang YT
    Nat Neurosci; 1999 May; 2(5):401-3. PubMed ID: 10321240
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies of the renal action of melatonin: evidence that the effects are mediated by 37 kDa receptors of the Mel1a subtype localized primarily to the basolateral membrane of the proximal tubule.
    Song Y; Chan CW; Brown GM; Pang SF; Silverman M
    FASEB J; 1997 Jan; 11(1):93-100. PubMed ID: 9034171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications.
    Donnelly D; Maudsley S; Gent JP; Moser RN; Hurrell CR; Findlay JB
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):55-61. PubMed ID: 10085227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin receptors in rat hippocampus: molecular and functional investigations.
    Musshoff U; Riewenherm D; Berger E; Fauteck JD; Speckmann EJ
    Hippocampus; 2002; 12(2):165-73. PubMed ID: 12000116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor.
    Conway S; Mowat ES; Drew JE; Barrett P; Delagrange P; Morgan PJ
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1229-36. PubMed ID: 11302748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin receptor pharmacology: toward subtype specificity.
    Sugden D; Pickering H; Teh MT; Garratt PJ
    Biol Cell; 1997 Nov; 89(8):531-7. PubMed ID: 9618903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pharmacology and function of melatonin receptor subtypes.
    Dubocovich ML; Masana MI; Benloucif S
    Adv Exp Med Biol; 1999; 460():181-90. PubMed ID: 10810513
    [No Abstract]   [Full Text] [Related]  

  • 29. Melatonin receptors in human uveal melanocytes and melanoma cells.
    Roberts JE; Wiechmann AF; Hu DN
    J Pineal Res; 2000 Apr; 28(3):165-71. PubMed ID: 10739303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of human melatonin 1b receptor gene in circadian rhythm sleep disorders and controls.
    Ebisawa T; Uchiyama M; Kajimura N; Kamei Y; Shibui K; Kim K; Kudo Y; Iwase T; Sugishita M; Jodoi T; Ikeda M; Ozeki Y; Watanabe T; Sekimoto M; Katoh M; Yamada N; Toyoshima R; Okawa M; Takahashi K; Yamauchi T
    Neurosci Lett; 2000 Feb; 280(1):29-32. PubMed ID: 10696804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor.
    Mseeh F; Gerdin MJ; Dubocovich MI
    Eur J Pharmacol; 2002 Aug; 449(1-2):29-38. PubMed ID: 12163103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity relationships within a series of melatonin analogs and related indolealkylamines.
    Lewis DF; Arendt J; English J
    J Pharmacol Exp Ther; 1990 Jan; 252(1):370-3. PubMed ID: 2153808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of melatonin on myocardial infarction.
    Chen Z; Chua CC; Gao J; Hamdy RC; Chua BH
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1618-24. PubMed ID: 12679327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.
    Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G
    J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin receptors and ligands.
    Witt-Enderby PA; Li PK
    Vitam Horm; 2000; 58():321-54. PubMed ID: 10668404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain.
    Reppert SM; Weaver DR; Cassone VM; Godson C; Kolakowski LF
    Neuron; 1995 Nov; 15(5):1003-15. PubMed ID: 7576645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The high affinity melatonin binding site probed with conformationally restricted ligands--II. Homology modeling of the receptor.
    Grol CJ; Jansen JM
    Bioorg Med Chem; 1996 Aug; 4(8):1333-9. PubMed ID: 8879555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies.
    Brydon L; Barrett P; Morgan PJ; Strosberg AD; Jockers R
    Adv Exp Med Biol; 1999; 460():215-20. PubMed ID: 10810516
    [No Abstract]   [Full Text] [Related]  

  • 39. An updated phylogenetic analysis of vertebrate melatonin receptor sequences: reflection on the melatonin receptor nomenclature by the Nomenclature Subcommittee of the International Union of Pharmacology.
    Shiu SY; Pang SF
    Biol Signals Recept; 1998; 7(4):244-8. PubMed ID: 9730584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin and cardiovascular function.
    Krause DN; Geary GG; Doolen S; Duckles SP
    Adv Exp Med Biol; 1999; 460():299-310. PubMed ID: 10810525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.